Surgical management is associated with improved survival for endocarditis after transcatheter aortic valve replacement.

IF 3.3 2区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS
Annals of cardiothoracic surgery Pub Date : 2025-03-31 Epub Date: 2024-11-12 DOI:10.21037/acs-2024-etavr-0103
Shinichi Fukuhara, Taichi Suzuki, G Michael Deeb, Gorav Ailawadi, Himanshu J Patel, Bo Yang, Sami El-Dalati
{"title":"Surgical management is associated with improved survival for endocarditis after transcatheter aortic valve replacement.","authors":"Shinichi Fukuhara, Taichi Suzuki, G Michael Deeb, Gorav Ailawadi, Himanshu J Patel, Bo Yang, Sami El-Dalati","doi":"10.21037/acs-2024-etavr-0103","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Prosthetic valve endocarditis is a rare yet devastating complication following transcatheter aortic valve replacement (TAVR). This study aims to investigate the outcomes of surgical versus medical management of post-TAVR endocarditis.</p><p><strong>Methods: </strong>Between 2011 and 2024, 67 patients with post-TAVR endocarditis were identified, comprising 24 (35.8%) patients managed surgically and 43 (64.2%) managed medically. All cases were reviewed by our multidisciplinary endocarditis team to determine the optimal treatment strategy.</p><p><strong>Results: </strong>The overall incidence of post-TAVR endocarditis was 1.4%. The number of endocarditis cases increased over time from 1-2 in 2015-2018 to 18 in 2023. The most frequent source of endocarditis was unknown (32.8%), and the predominant causative organism was enterococcus species (25.4%). Notably, among the 43 medically managed patients, 19 (44.2%) exhibited surgical indications, predominantly due to large vegetations with or without embolic complications (n=11; 57.9%). The medical management group had a higher proportion of females and more frequent use of self-expandable valves compared to the surgical group. The time interval between TAVR and endocarditis diagnosis was similar across both groups. In the surgically managed cohort, isolated aortic valve replacement was uncommon, with most patients undergoing complex TAVR explantations coupled with concomitant procedures, most frequently aortic root repair (n=11; 45.8%). The 30-day and 1-year mortality rates for the three groups (surgical, medical without surgical indications, and medical with surgical indications) were 0%, 4.2%, and 31.6% (P=0.002), and 4.2%, 20.8%, and 73.7% (P<0.001), respectively.</p><p><strong>Conclusions: </strong>Surgical management was associated with significantly improved survival compared to medical management for post-TAVR endocarditis. The poor clinical outcomes in the medically managed group were primarily due to patients who did not undergo surgery despite having surgical indications. Prudent clinical judgment and timely surgical intervention when indicated are critical to enhancing the overall clinical outcomes of this challenging condition.</p>","PeriodicalId":8067,"journal":{"name":"Annals of cardiothoracic surgery","volume":"14 2","pages":"141-150"},"PeriodicalIF":3.3000,"publicationDate":"2025-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12013770/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of cardiothoracic surgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.21037/acs-2024-etavr-0103","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/11/12 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Prosthetic valve endocarditis is a rare yet devastating complication following transcatheter aortic valve replacement (TAVR). This study aims to investigate the outcomes of surgical versus medical management of post-TAVR endocarditis.

Methods: Between 2011 and 2024, 67 patients with post-TAVR endocarditis were identified, comprising 24 (35.8%) patients managed surgically and 43 (64.2%) managed medically. All cases were reviewed by our multidisciplinary endocarditis team to determine the optimal treatment strategy.

Results: The overall incidence of post-TAVR endocarditis was 1.4%. The number of endocarditis cases increased over time from 1-2 in 2015-2018 to 18 in 2023. The most frequent source of endocarditis was unknown (32.8%), and the predominant causative organism was enterococcus species (25.4%). Notably, among the 43 medically managed patients, 19 (44.2%) exhibited surgical indications, predominantly due to large vegetations with or without embolic complications (n=11; 57.9%). The medical management group had a higher proportion of females and more frequent use of self-expandable valves compared to the surgical group. The time interval between TAVR and endocarditis diagnosis was similar across both groups. In the surgically managed cohort, isolated aortic valve replacement was uncommon, with most patients undergoing complex TAVR explantations coupled with concomitant procedures, most frequently aortic root repair (n=11; 45.8%). The 30-day and 1-year mortality rates for the three groups (surgical, medical without surgical indications, and medical with surgical indications) were 0%, 4.2%, and 31.6% (P=0.002), and 4.2%, 20.8%, and 73.7% (P<0.001), respectively.

Conclusions: Surgical management was associated with significantly improved survival compared to medical management for post-TAVR endocarditis. The poor clinical outcomes in the medically managed group were primarily due to patients who did not undergo surgery despite having surgical indications. Prudent clinical judgment and timely surgical intervention when indicated are critical to enhancing the overall clinical outcomes of this challenging condition.

手术处理与经导管主动脉瓣置换术后心内膜炎患者生存率的提高有关。
背景:人工瓣膜心内膜炎是经导管主动脉瓣置换术(TAVR)后罕见但毁灭性的并发症。本研究旨在探讨tavr术后心内膜炎的手术治疗与内科治疗的结果。方法:2011年至2024年,共发现67例tavr后心内膜炎患者,其中手术治疗24例(35.8%),药物治疗43例(64.2%)。我们的多学科心内膜炎小组对所有病例进行了审查,以确定最佳治疗策略。结果:tavr术后心内膜炎的总发生率为1.4%。随着时间的推移,心内膜炎病例从2015-2018年的1-2例增加到2023年的18例。心内膜炎最常见的病因不明(32.8%),主要病原菌为肠球菌(25.4%)。值得注意的是,在43例医学管理的患者中,19例(44.2%)表现出手术指征,主要是由于大面积植被伴或不伴栓塞并发症(n=11;57.9%)。与手术组相比,内科管理组女性比例更高,使用自膨胀瓣膜的频率更高。TAVR和心内膜炎诊断之间的时间间隔在两组中相似。在手术治疗的队列中,孤立主动脉瓣置换术并不常见,大多数患者接受复杂的TAVR解释并伴随手术,最常见的是主动脉根部修复(n=11;45.8%)。三组(手术、内科无手术指征和内科有手术指征)的30天和1年死亡率分别为0%、4.2%和31.6% (P=0.002), 4.2%、20.8%和73.7% (P结论:与内科治疗相比,tavr后心内膜炎的手术治疗可显著提高生存率。医学管理组的临床结果较差主要是由于患者尽管有手术指征但未接受手术。谨慎的临床判断和及时的手术干预对于提高这种具有挑战性的疾病的整体临床结果至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
4.60
自引率
0.00%
发文量
58
期刊介绍: Information not localized
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信